Rothschild & CO Asset Management Us Inc. Jazz Pharmaceuticals PLC Transaction History
Rothschild & CO Asset Management Us Inc.
- $6.56 Billion
- Q4 2022
A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 52,249 shares of JAZZ stock, worth $6.09 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
52,249
Previous 58,817
11.17%
Holding current value
$6.09 Million
Previous $7.84 Million
6.16%
% of portfolio
0.13%
Previous 0.13%
Shares
17 transactions
Others Institutions Holding JAZZ
# of Institutions
587Shares Held
60.1MCall Options Held
424KPut Options Held
190K-
Black Rock Inc. New York, NY6.15MShares$717 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.02MShares$702 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.47MShares$288 Million0.73% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.33MShares$271 Million0.07% of portfolio
-
State Street Corp Boston, MA1.97MShares$229 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.31B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...